rss
Br J Ophthalmol 89:1109-1111 doi:10.1136/bjo.2004.063024
  • Clinical science
    • Scientific reports

Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation

Table 1

 Patient and CNV characteristics, treatments, and outcomes

Patient/sex/diagnosis/age (years) Initial fluorescein angiogram PDT Intravitreal triamcinolone/other Vision changes†
Size* (μm) % blood Initial VA Final VA Change in letters
*Size (μm): greatest linear dimension of entire CNV complex (CNV + haemorrhage + elevated blocked fluorescence).
†Vision measured on a logMAR chart. Median initial VA 20/160 and median final VA 20/50. POHS, presumed ocular histoplasmosis syndrome; PIC, punctate inner choroidopathy; PDT, photodynamic therapy; VA, visual acuity.
1/M/POHS/39 3200 25–50 3 1 20/250 20/250 1
2/F/POHS/40 2400 0 1 1 20/200 20/125 15
3/F/POHS/29 800 0 3 1 20/40 20/25 7
MMF, Tacrolimus
4/F/PIC/23 970 1–24 2 1 20/50 20/32 10
5/F/PIC/31 1200 0 2 MMF, Tacrolimus 20/100 20/40 21
6/F/intermediate uveitis/23 1300 0 1 2 20/200 20/40 36

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.